ResearcherTokyo Metropolitan Komagome HospitalActive in the last 2 years
Jun Nakahodo
Matched on ORCID iD 0000-0003-1434-3410; OpenAlex author ID A5080632931. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 6
- Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. First author DOI 10.1007/s12328-026-02398-x↗
- Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichment: An AI-Assisted Volumetric Study. Co-author DOI 10.3390/cancers18183062↗
- Focal pancreatic parenchymal atrophy could be a precursor of pancreatic cancer. First author DOI 10.1016/j.pan.2025.01.003↗
- Endoscopic Ultrasound Can Differentiate High-Grade Pancreatic Intraepithelial Neoplasia, Small Pancreatic Ductal Adenocarcinoma, and Benign Stenosis. Co-author DOI 10.5009/gnl220521↗
- Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. Co-author DOI 10.1016/j.pan.2022.10.003↗
- Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer. Last author DOI 10.3390/diagnostics9010015↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kazuro Chiba · 5 shared papers, 2019–2026 · strength 1.15
- Paper Focal pancreatic parenchymal atrophy could be a precursor of pancreatic cancer. DOI 10.1016/j.pan.2025.01.003↗
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Masataka Kikuyama · 5 shared papers, 2019–2026 · strength 1.15
- Paper Focal pancreatic parenchymal atrophy could be a precursor of pancreatic cancer. DOI 10.1016/j.pan.2025.01.003↗
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Terumi Kamisawa · 4 shared papers, 2019–2026 · strength 0.79
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Paper Focal pancreatic parenchyma atrophy is a harbinger of pancreatic cancer and a clue to the intraductal spreading subtype. DOI 10.1016/j.pan.2022.10.003↗
- Ryogo Minami · 2 shared papers, 2026 · strength 0.53
- Paper Association between autoimmune pancreatitis and pancreatic cancer: a case after long-term steroid therapy. DOI 10.1007/s12328-026-02398-x↗
- Paper Accelerated Pancreatic Volume Loss as a Potential Pre-Diagnostic Imaging Biomarker for Pancreatic Cancer Risk Enrichmen… DOI 10.3390/cancers18183062↗
- Goro Honda · 2 shared papers, 2019–2025 · strength 0.46
- Masanao Kurata · 1 shared paper, 2026 · strength 0.24
- Masakazu Toi · 1 shared paper, 2026 · strength 0.24
- Kentaro Yamao · 1 shared paper, 2024 · strength 0.20
- Ryota Sagami · 1 shared paper, 2024 · strength 0.20
- Kenji Yamao · 1 shared paper, 2024 · strength 0.20
- Kazunari Murakami · 1 shared paper, 2024 · strength 0.20
- Hideyuki Kanemoto · 1 shared paper, 2019 · strength 0.09
- Shuzo Terada · 1 shared paper, 2019 · strength 0.09
- Sawako Kuruma · 1 shared paper, 2019 · strength 0.09
- Shinya Kawaguchi · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.